Generation of New Knock-Out Mouse Strains of Lysophosphatidic Acid Receptor 1
Open Access
- 20 March 2025
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 26 (6) , 2811
Abstract
The lysophosphatidic acid receptor 1 (LPAR1) is one of the six cognate G protein-coupled receptors of the bioactive, growth factor-like phospholipid lysophosphatidic acid (LPA). LPAR1 is widely expressed in different cell types and mediates many LPA effects. LPAR1 has been implicated in several chronic inflammatory diseases, and especially pulmonary fibrosis, where it has been established as a promising therapeutic target. Herein, we present the generation of several Lpar1 mouse strains through genetic recombination. These strains include an initial versatile Lpar1 strain (tm1a) from which three other strains derive: an Lpar1 reporter knockout strain (tm1b) where LacZ has replaced exon 3 of Lpar1; a “floxed” Lpar1 strain (tm1c), where exon 3 is flanked by two loxP sites allowing conditional, cell-specific Lpar1 inactivation; and a complete KO strain of Lpar1 (tm1d), where exon 3 has been deleted. The generated strains are novel genetic tools, that can have various applications in studying LPA-LPAR1 signaling and its role in normal physiology and disease.Keywords
Funding Information
- Hellenic Foundation for Research and Innovation (3565, 01144)
This publication has 56 references indexed in Scilit:
- Pharmacokinetics of Fipaxalparant, a Small‐Molecule Selective Negative Allosteric Modulator of Lysophosphatidic Acid Receptor 1, and the Effect of Food in Healthy VolunteersClinical Pharmacology in Drug Development, 2024
- Generation of an Lpar1-EGFP Fusion Knock-in Transgenic Mouse LineCell Biochemistry and Biophysics, 2021
- Activation of Macrophages by Lysophosphatidic Acid through the Lysophosphatidic Acid Receptor 1 as a Novel Mechanism in Multiple Sclerosis PathogenesisMolecular Neurobiology, 2020
- microRNA‐501‐5p promotes cell proliferation and migration in gastric cancer by downregulating LPAR1Journal of Cellular Biochemistry, 2019
- Antidepressant amitriptyline‐induced matrix metalloproteinase‐9 activation is mediated by Src family tyrosine kinase, which leads to glial cell line‐derived neurotrophic factor mRNA expression in rat astroglial cellsNeuropsychopharmacology Reports, 2019
- Lysophosphatidic Acid Receptor 1 Antagonist SAR100842 for Patients With Diffuse Cutaneous Systemic SclerosisArthritis & Rheumatology, 2017
- Loss of lysophosphatidic acid receptor LPA1 alters oligodendrocyte differentiation and myelination in the mouse cerebral cortexBrain Structure and Function, 2014
- Necessity of Lysophosphatidic Acid Receptor 1 for Development of ArthritisArthritis & Rheumatism, 2013
- Opposite roles of LPA1 and LPA3 on cell motile and invasive activities of pancreatic cancer cellsTumor Biology, 2012
- Amelioration of dermal fibrosis by genetic deletion or pharmacologic antagonism of lysophosphatidic acid receptor 1 in a mouse model of sclerodermaArthritis & Rheumatism, 2011